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Infectious pancreatic necrosis virus (IPNV) infection has been amajor problem in salmonid
aquaculture. Marker-assisted selection of individuals with resistant genotype at the major
IPN quantitative trait locus (IPN-QTL) has significantly reduced mortality in recent years.
We have identified host miRNAs that respond to IPNV challenge in salmon fry that were
either homozygous resistant (RR) or homozygous susceptible (SS) for the IPN-QTL.
Small RNA-sequenced control samples were compared to samples collected at 1, 7,
and 20 days post challenge (dpc). This revealed 72 differentially expressed miRNAs (DE
miRNAs). Viral load (VL) was lower in RR vs. SS individuals at 7 and 20 dpc. However,
analysis of miRNA expression changes revealed no differences between RR vs. SS
individuals in controls, at 1 or 7 dpc, while 38 “high viral load responding” miRNAs
(HVL-DE miRNAs) were identified at 20 dpc. Most of the HVL-DE miRNAs showed
changes that were more pronounced in the high VL SS group than in the low VL
RR group when compared to the controls. The absence of differences between QTL
groups in controls, 1 and 7 dpc indicates that the QTL genotype does not affect miRNA
expression in healthy fish or their first response to viral infections. The miRNA differences
at 20 dpc were associated with the QTL genotype and could, possibly, contribute to
differences in resistance/susceptibility at the later stage of infection. In silico target gene
predictions revealed that 180 immune genes were putative targets, and enrichment
analysis indicated that the miRNAs may regulate several major immune system
pathways. Among the targets of HVL-DE miRNAs were IRF3, STAT4, NFKB2, MYD88,
and IKKA. Interestingly, TNF-alpha paralogs were targeted by different DE miRNAs.
Woldemariam et al. miRNAs Responding to IPNV Infection
Most DE miRNAs were from conserved miRNA families that respond to viral infections
in teleost (e.g., miR-21, miR-146, miR-181, miR-192, miR-221, miR-462, miR-731, and
miR-8159), while eight were species specific. The miRNAs showed dynamic temporal
changes implying they would affect their target genes differently throughout disease
progression. This shows that miRNAs are sensitive to VL and disease progression, and
may act as fine-tuners of both immediate immune response activation and the later
inflammatory processes.
Keywords: Atlantic salmon, microRNA, IPNV, immune response, host-virus interactions
INTRODUCTION
MicroRNAs (miRNAs) are small (20–24 nts) non-coding RNAs
that regulate gene expression at the post-transcriptional level by
binding to mRNA transcripts (target genes) in a sequence specific
manner (1, 2). As part of the miRISC complex, they fine-tune
gene expression by degrading target mRNAs or by interfering
with their translation (3–5). There are several hundred miRNA
genes in vertebrate species (http://mirbase.org/), and each of
these contribute to the regulation of multiple biological processes
(6–8). Several studies in higher vertebrates indicate that the host
immune defense against viral infections are among the processes
regulated by miRNAs (9–11).
Our previous study on miRNAs and host-virus interactions in
Atlantic salmon revealed several evolutionary conserved miRNA
families that responded to salmonid alphavirus (SAV) infection
(12). Among these conserved miRNAs were miR-21, miR-146,
miR-181, and the clusteredmiRNAsmiR-462 andmiR-731. Some
of these also revealed differences in miRNA expression when
fish were challenged by SAV-subtypes with diverging mortality
(12). Although the functional analysis of these miRNAs is still
in progress, the responding miRNAs were predicted to target
several genes involved in innate immune and inflammatory
responses, suggesting that these host miRNAs were directly
involved in regulation of the Atlantic salmon antiviral immune
responses. Andreassen and Høyheim (13) proposed a model
which suggests a role for miRNAs as fine-tuning modulators of
immune responses during viral infections in teleost. The model
suggests that at normal healthy state, the constitutive expression
of miRNAs targeting immune activator transcripts restricts the
triggering of an immune response. When a viral infection occurs,
miRNAs can take on a dual role that help to fine-tune the immune
response in order to benefit the host. Downregulation of host
miRNAs that target immune response activator genes at the early
stage of viral infection may, for example, lead to an increased
expression of the immune response activators, and consequently
promote activation of the host immune responses. Upregulated
expression of miRNAs that target activators of inflammation in
the later stages of infection could, on the other hand, balance
the magnitude of the response, and help prevent escalation of
inflammatory processes to a level that could be harmful to the
host (13).
Infectious pancreatic necrosis virus (IPNV), a member of
the virus family Birnaviridae, is a non-enveloped birnavirus
causing infectious pancreatic necrosis (IPN). IPN is a disease
associated with high mortality mainly in juvenile salmonids,
including Atlantic salmon fry (14), but considerable mortalities
from IPN have also been reported in Atlantic salmon post-
smolts (15). In recent years, the number of outbreaks and
losses due to IPN have been significantly reduced (16). This
decline can mainly be attributed to the discovery of a major
quantitative trait locus (IPN-QTL) associated with a heritable
difference in IPN-resistance (17, 18), that has been applied
in marker-assisted breeding of IPN resistant fish. A single-
nucleotide polymorphism (SNP) found in the epithelial cadherin
gene (Cdh1) has been suggested as contributing to the resistance
associated with the IPN-QTL (19). The Cdh1 gene encodes
a calcium-dependent cell adhesion protein with key roles in
epithelial cell behavior, tissue formation, and suppression of
cancer (20). A significant association between the IPN-QTL
and the SNP has been reported (19). Results from an in vitro
study applying an immunofluorescence detection of IPNV and
the Cdh1-1 protein bound to IPNV suggested that entry of the
virus was facilitated in hepatocytes from individuals with the
susceptible variant of the SNP, while the ability of the virus to
enter hepatocytes was restricted in individuals with the resistant
SNP variant (19). The findings suggested that the functional
role of the gene involves internalization of IPNV virions into
the host (19). However, subsequent research has shown that
virions can enter the cells of resistant salmon (21), and that
the clathrin-mediated endocytosis proposed in (19) is not the
entry mechanism used by IPNV to enter Atlantic salmon cells in
culture (22). Therefore, the nature of the mechanisms leading to
the heritable differences in resistance to IPN associated with the
IPN-QTL are not fully understood (19, 21).
IPNV is one of the most intensely studied viruses of fish, and
some studies have investigated the gene expression responses
to IPNV (23–29). Recently, Robledo et al. (21) studied the
gene expression profiles of IPNV challenged Atlantic salmon
fry from families showing large differences in susceptibility
to IPN. Their findings demonstrated significant differences in
the immune responses between families that were classified
as either “IPN-resistant” or “IPN-susceptible.” The susceptible
families were characterized by a large early innate immune
response, while a moderate, putatively macrophage-mediated
inflammatory response was characteristic for the IPN-resistant
families. The information from these transcriptomic studies
has provided valuable insights into some of the mechanisms
of host immune responses to IPNV. In spite of the emerging
evidence that miRNAs are important regulators of host immune
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responses, no studies have focused on the roles of miRNAs in host
response to IPNV and whether they contribute to susceptibility
or resistance to disease.
The aim of this study was to identify Atlantic salmon miRNAs
that are differentially expressed in response to IPNV challenge
(DE miRNAs). Samples were analyzed at three time points post
challenge to identify miRNAs responding at different infection
stages following the viral challenge. In contrast to the SAV study
where we investigated the miRNA response in fish infected by
different virus subtypes (12), this study aimed at investigating
whether there was any association between miRNA response
and viral copy number, or if there were differences in response
associated with the IPN-QTL. Materials were sourced from
a family where the selected offspring were homozygous for
either the resistant or the susceptible genotype at the IPN-QTL.
Small RNA sequencing followed by miRNA expression analysis
identified miRNAs that showed modulation in their expression
associated with viral load and/or genotype at the IPN-QTL.
Finally, the regulation of host antiviral immunity against IPNV
by DE miRNAs was further explored by in silico target gene
prediction to identify miRNA-target gene interactions associated
with immune response, inflammation and/or apoptosis.
MATERIALS AND METHODS
Materials
The salmon fry were collected as part of a larger challenge
experiment described in Houston et al. (30). The challenges
were performed at the Center for Environment, Fisheries and
Aquaculture Science (Cefas) under the approval of their ethical
review committee and complied with the Animals Scientific
Procedures Act. The fish were sampled and euthanized using
a procedure specifically listed on the appropriate Home Office
(UK) license.
The Atlantic salmon fry were from family C described in
Houston et al. (30). Parents were heterozygous (RS) at the
IPN-QTL (17). The offspring included in this study were of
either the homozygous susceptible (SS) or homozygous resistant
(RR) genotype at the IPN-QTL. The QTL-genotyping was
carried out as described in Houston et al. (30). Fry were bath
challenged with IPNV isolate V0512-1 (serotype A2 (Sp)). They
were sampled at 1 day post challenge (1 dpc), 7 days post
challenge (7 dpc) and 20 days post-challenge (20 dpc). Twelve
fry, six with the homozygous resistant genotype (RR) and six
with the homozygous susceptible genotype (SS), were selected
from each of the time points post-challenge (n = 36). Healthy
controls were sampled prior to bath challenge (n = 11). The
total materials were, thus, 47 samples including the healthy
controls. Houston et al. (30) reported the mortalities from the
challenge trials. Mortalities were on average 63% if individuals
were SS (homozygous susceptible genotype), while it was 5% if
individuals were RS (heterozygous genotype) and 0% if fish were
RR (homozygous resistant genotype). None of the control fish
developed IPN or died (mortality= 0%). Detailed descriptions of
the rearing conditions of the fry, virus preparation and challenge
protocol are given in Houston et al. (30).
Methods
Small RNA Isolation
Total RNA was isolated from the whole fry samples using
TRI reagent (Sigma–Aldrich R©, St. Louis, MO, USA) following
the manufacturer’s instructions as described in Houston et al.
(30). The whole fry homogenate was used in the total RNA
extraction. The RNA quality and quantity were determined
using spectrophotometry (NanoDrop ND-1000, Thermo
Scientific, Wilmington, USA) and agarose gel electrophoresis.
The A260/280 ratios were higher than 1.9 in all the samples (see
Table S1).
Quantitation of Viral Loads by RT-qPCR
Viral loads of IPNV were determined by quantitative RT-qPCR
using QIAGEN R© oneStep RT-PCR kit (Qiagen GmBH, Hilden,
Germany). The primers and probes were designed to amplify
a fragment of 109 bp in the VP3 region of IPNV serotype
Sp, and samples were analyzed as described in Orpetveit et al.
(31). Samples with quantification cycle (Cq) values of ≤ 40
were considered positive. Mann-Whitney U tests performed by
SPSS version 24.0 (SPSS Inc., Chicago, IL, USA) were used for
statistical comparisons of the viral loads (determined through
Cq values) between the IPN-QTL resistant (RR) and IPN-QTL
susceptible (SS) groups. P < 0.05 were considered significant.
Confirmation of the IPNV type used for the challenge was
obtained by sequencing the capsid protein VP2 using primers
described in Santi et al. (32). The sequencing was performed
using the BigDyeTM Terminator v3.1 Cycle Sequencing Kit and
a 24-capillary 3500xL Genetic Analyzer, both from Applied
Biosystems (Foster City, CA, USA) as described in (32).
Library Construction, High-Throughput Sequencing,
and DESeq2 Analysis
Small RNA libraries were constructed and sequenced at the
Norwegian High-Throughput Sequencing Center (NSC). The
NEBNext R© Multiplex Small RNA Library Prep Set for Illumina
(New England Biolabs, Inc. Ipswich, MA, USA) was used in
the preparation of 47 libraries from the 36 IPNV challenged
samples and the 11 controls. Total RNA, 1 µg per sample, was
used as input in the library preparation in accordance with the
manufacturer’s protocols. Small RNAs isolated from the 47 whole
fry were ligated with 3′ and 5′ RNA adapters, followed by reverse
transcription and PCR enrichment using barcoded RT-primers.
The cDNA products were purified using 6% polyacrylamide gels,
and size selection of fragments (∼145–160 bp) was carried out to
enrich for miRNAs. The sequencing was performed at NSC on a
NextSeq 500 from Illumina, producing 75 base single-end reads.
Data processing of the raw reads followed the procedures
described in Woldemariam et al. (33). The raw reads were
quality checked using FASTQC (v.0.11.55) (34) and processed
with cutadapt (v.1.18) (35). This process removed low quality
reads, adapter-only sequences and reads outside the expected
size range of mature miRNAs (18–25 nts). Subsequently,
the clean sequence reads (18–25 nts) were mapped to a
genome index consisting of all known mature miRNAs in
Atlantic salmon (33) using STAR (v.2.5.2b) (36). All sequencing
reads have been submitted to the National Center for
Frontiers in Immunology | www.frontiersin.org 3 September 2020 | Volume 11 | Article 2113
Woldemariam et al. miRNAs Responding to IPNV Infection
Biotechnology Information (NCBI), to the public repository for
the next-generation sequence data, the Sequence Read Archive
(SRA) (https://www.ncbi.nlm.nih.gov/sra/).
The alignment files were further processed in R using the
featureCounts function from the Rsubread package (37) to
produce count matrices. These count tables were used as input in
the Bioconductor package DESeq2 (v.1.20.0) in R (38) to analyze
differential miRNA expression. Differentially expressed miRNAs
(DE miRNAs) at each of the time points (1, 7, and 20 days post
challenge) were identified by comparing control group and all
challenged individuals at each time point. Furthermore, IPN-
QTL resistant (RR) and IPN-QTL susceptible (SS) groups were
also compared at each time point to identify miRNAs associated
with IPN-QTL genotype. Differentially expressed miRNAs were
defined as all miRNAs with Benjamini-Hochberg adjusted p ≤
0.05, log2 fold change threshold value of at least≤−1.0 or≥ 1.0,
and with normalized read counts (from DESeq2 analysis) ≥ 5 in
each sample. Unsupervised hierarchical clustering analysis was
then performed using the hclust function from the stats package
in R, with the Euclidean distance metric and Ward’s method
for clustering (39). Heatmaps and cluster dendograms with
the differentially expressed miRNAs grouped by the clustering
analysis were plotted using the heatmap.2 function in the R
package gplots (v.3.0.1.1) (40).
Target Gene Predictions
Target gene prediction (in silico analysis) was carried out with
RNAhybrid (41). The mature sequences from the DE miRNAs
[mature sequences given in Woldemariam et al. (33)] were
tested against 3’UTRs from all Atlantic salmonmRNA transcripts
in the NCBI Reference Sequence database (Refseq) (42). The
following parameters were applied in the RNA hybrid analysis:
helix constraint 2–8, no G: U in seed and minimum free
energy threshold−18 kcal/mol. Gene functions of predicted
target genes were retrieved from the Universal Protein Resource
(UniProt) database https://www.uniprot.org/ (43). Based on
the GO annotations, the subsets of target genes relevant to
immune response were identified. Cross-reference links for
these genes in Uniprot were used to retrieve organism-specific
gene pathways from the online resource Kyoto Encyclopedia
of Genes and Genomes (KEGG) pathway database (https://
www.genome.jp/kegg/pathway.html) (44). These genes were also
used as input in gene pathway enrichment analyses applying
the Enrichr tool (http://amp.pharm.mssm.edu/Enrichr/). Results
were then filtered by organism to rank gene pathways present
in Atlantic salmon by their adjusted P-values (Q-values) and
combined score.
Genes With Expression Changes at 20 dpc
Dr. Diego Robledo and colleagues provided information from
a microarray experiment identifying genes responding to IPNV
challenge at 20 dpc (log fold change of gene expression level at
least≤−1.0 or≥ 1.0). The fry used in thismicroarray experiment
were the samematerials as used in the current study (unpublished
data by Robledo et al.). A subset (n = 25) of the genes identified
as IPNV responsive at 20 dpc were among those immune genes
that were predicted as target genes of the miRNAs identified
in family C from the comparison of IPN-QTL susceptible (SS)
and IPN-QTL resistant (RR) individuals at 20 dpc. These 25
immune genes and the miRNAs all showed expression changes
following IPNV challenge in same materials and at the same time
point.We therefore compared themagnitude and direction of the
expression changes in these genes and miRNAs to gain further
insights into their putative interactions.
RESULTS
Measurements of Viral Loads
IPNV RNA was successfully detected and quantified by RT-
qPCR. Six of the 11 controls showed very low (Cq > 37), but
still positive results of viral presence. There were no differences in
miRNA expression between these six controls (Cq > 37) and the
other negative controls (Cq > 40) (data not shown) indicating
that these controls had not been exposed to IPNV at the initial
stage of the challenge. Thus, all 11 samples were used as controls
in the miRNA expression analyses (see Differentially expressed
miRNAs (DE-miRNAs) show dynamic expression patterns post
challenge and miRNAs associated with IPN-QTL genotype and
prolonged high viral loads), five of which were homozygous
resistant (RR) and six that were homozygous susceptible (SS)
for the IPN-QTL. The presence of very low levels of IPNV
could be caused by contamination of some controls somewhere
in the analysis pipeline. To elucidate whether this could be
the cause, the viral capsid protein VP2 sequence was amplified
and sequenced in the positive controls and in some samples
from challenged fish with high viral loads collected at later time
points. The VP2 sequences from all these samples were identical
supporting a contamination of these controls with virus from the
same source as was used in the challenge trial.
The viral load was measured in all challenged individuals at
1, 7, and 20 dpc. These measurements showed that IPNV could
be detected in both RR and SS fish as early as 1 dpc (Figure 1).
The 1 dpc measurements were similar in all samples with an
average Cq value of 32.5 in both RR and SS. Thus, the response
to challenge measured by their viral load did not differ between
IPN-QTL genotypes at this early stage of infection. There were,
however, significant differences between the QTL groups (RR and
SS) at both 7 and 20 dpc, with an ∼1,000-fold higher viral load
in the IPN-QTL SS group than in the IPN-QTL RR group (p
≤ 0.01). The higher viral loads observed in the SS group was
in accordance with the expectations that individuals that were
homozygous for the susceptible QTL-genotype would develop a
more severe viral infection.
RNA Library Preparation and Small RNA
Sequencing
To identify Atlantic salmon miRNAs responding to IPNV
infection RNA was successfully extracted from 47 whole fry and
all samples were subsequently small-RNA sequenced. A total of
799,382,140 raw reads were obtained from the IPNV challenged
samples (n = 36) and the healthy controls (n = 11). The quality
filtered (Phred score > 32), adapter and size trimmed reads for
each sample ranged from 2.9 to 15.3 million. The proportion
of clean reads that mapped uniquely to the reference Atlantic
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FIGURE 1 | Average viral load in IPN-QTL resistant (RR) and IPN-QTL susceptible (SS) fry at 1, 7, and 20 dpc. The significance symbols represent the p-values for
Mann-Whitney U-test between the RR and SS (ns: means p > 0.05 (not significant), **: means p ≤ 0.01).
salmon miRNAome ranged from 56.3–77.8%. An overview of
sample origin, RNA concentration, read numbers, reads mapped
tomiRNAs and the SRA accession numbers are given inTable S1.
Overall, the sequence reads produced from each sample were of
high quality and suitable for differential expression analysis.
Differentially Expressed miRNAs
(DE-miRNAs) Show Dynamic Expression
Patterns Post Challenge
To identify miRNAs that showed expression changes in response
to IPNV infection, we initially compared the expression of
miRNAs in controls against samples from 1, 7 and 20 days
post challenge. This analysis revealed 72 mature miRNAs
belonging to 42miRNA families that were differentially expressed
(DE) relative to controls on at least one of the three time
points. Additionally, to identify miRNAs that were associated
with resistance/susceptibility, we also compared the IPN-QTL
susceptible genotype groups (SS) against IPN-QTL resistant
genotype groups (RR) at all timepoints. This was done to reveal
miRNAs that could putatively be involved inmechanisms leading
to resistance in the RR group and susceptibility in the SS group.
Differences in miRNA expression between RR and SS were only
found at 20 dpc. There were 38 such miRNAs, but 28 of these
miRNAs were also among the 72 miRNAs identified in the initial
analysis of different time points against controls. An overview
of all the 82 DE genes identified in the time point analysis’
and comparisons between genotypes are given in Table S2. The
supplementary table show results from the SS groups and the
RR groups separately. A detailed description of the 38 miRNAs
associated with differences in resistance/susceptibility (QTL-
genotypes) is given in section miRNAs associated with IPN-QTL
genotype and prolonged high viral loads.
The 82 DE miRNAs showed dynamic expression patterns
compared to controls. The RR group changes were slightly more
pronounced at 7 dpc, and more miRNAs were significantly
changed according to our thresholds (see methods) in this group
than in the SS group. The changes of the SS group miRNAs were,
however, very similar to the RR group. Although they were not
significantly different to controls they changed in same direction
(less expression than in controls) as in the RR group and were
not significantly different to this group. On the other hand, the
SS group showed the largest changes compared to controls at 20
dpc, and, inmany cases, were also significantly different to the RR
group. An overview of number of mature miRNAs different to
controls for each of the QTL groups at each time point is given in
Figure 2. In addition, the dynamic expression patterns for each
of the QTL groups are illustrated in Figures 3, 4. As shown in
Figure 3, the 47 DE miRNAs in the RR group at 7 dpc (Figure 2)
were down-regulated while the SS group revealed very similar,
although slightly less pronounced, changes in same direction as
in the RR group (7 dpc, Figure 4). One miRNA, ssa-miR-2184-
3p, showed more than a 4-fold increase in expression in both
the RR and SS group at 1 dpc, while ssa-miR-29d-5p, that also
showed increased expression in both groups at 1 dpc, was only
significantly different to controls in the SS group (Figures 2, 4).
There were 62 mature miRNAs differently expressed compared
to controls at 20 dpc in the SS group while three of these also
were different to controls in the RR group (Figure 2). As shown
in the expression pattern of Figure 4 there were 45 miRNAs from
the SS group that continued to decrease their expression at 20
dpc while 17 of the DE miRNAs increased their expression. The
three miRNAs significantly different to controls in the RR group
at 20 dpc (Figure 2) were all decreased and not different to the SS
group. In summary, at 20 dpc the RR group changed toward the
expression levels of controls while the SS group changed further
away from controls (both decreases and increases) and showed
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FIGURE 2 | Venn diagrams showing the number of miRNAs belonging to either the SS and/or the RR group that were significantly different to controls at either 1, 7,
or 20 days post IPNV-challenge (dpc).
differences that were significantly different to both controls as
well as to the RR group.
miRNAs Associated With IPN-QTL
Genotype and Prolonged High Viral Loads
The comparisons of the relative expression of miRNAs between
the two IPN-QTL genotype groups revealed no differentially
expressed miRNAs between the SS and RR in the control
group, at 1 dpc or at 7 dpc despite the observed difference
in viral loads associated with the IPN-QTL genotype at 7
dpc (Figure 1). However, the comparison at 20 dpc revealed
38 miRNAs, from 18 miRNA families, that were significantly
different expressed when comparing the SS group with high viral
load and the RR group with low viral load. Ten of these mature
miRNAs from five miRNA gene families were not observed
in the time point comparisons of challenged fry vs. controls
(RR or SS). These were: ssa-let-7a-1-3-3p, ssa-let-7b-3p, ssa-
let-7d-c-1-3p, ssa-miR-7a-2-6-3p, ssa-miR-18b-3p, ssa-miR-29b-
1-5p, ssa-miR-29b-2-5p, ssa-miR-29b-3-5p ssa-miR-29e-5p, and
ssa-miR-8159-5p. The 28 remaining DE miRNAs were among
the 72 DE miRNAs also showing significant differences when
the challenged fry from each time point were compared to
controls (Figure 2). The complete results on the 38 miRNAs
showing different expression in comparison of RR and SS groups
at 20 dpc and associated with prolonged differences in viral
load, hereafter termed as high viral load responding miRNAs
(HVL-DE miRNAs) are given in Table S3. This table shows the
comparisons of the SS group against controls, the RR group
against controls and the SS group against the RR group.
The miRNA expression differences between the SS group and
the RR group leading to 38 HVL-DE miRNAs at 20 dpc were
in most cases due to the SS group displaying changes that were
more pronounced when compared to the controls than the RR
group. While the low viral load RR group showed small changes
compared to controls (mostly non-significant), the magnitude
of change (increase or decrease) in the SS group with high
viral loads was larger. In addition, some miRNAs discovered
in the SS vs. RR comparison changed expression in different
directions when compared to the controls. While these miRNAs
were not significantly changed when either SS or RR groups were
compared to controls, they were significant when SS and RR were
compared to each other.
The changes in the 38 HVL-DE miRNAs were further
examined by unsupervised hierarchical clustering analysis of the
miRNAs differently expressed between RR and SS at 20 dpc. This
analysis showed that there were three major clusters as shown
in the heatmap in Figure 5. The miRNAs in Cluster 1 were
characterized by larger increases in the SS group with higher viral
loads, while the changes in the low viral load RR group were not
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FIGURE 3 | The dynamic expression profiles of miRNAs differentially expressed at either 1, 7, and/or 20 dpc in the RR group. The plot shows the expression changes
(log2foldchanges) for each of the miRNAs at each time point post IPNV-challenge relative to controls. Several of the miRNA genes in the same miRNA family showed
similar dynamics and to simplify the plot only the major expressed mature member of each family is presented in the plot. The complete results are given in Table S2.
FIGURE 4 | The dynamic expression profiles of miRNAs differentially expressed at either 1, 7, and/or 20 dpc in the SS group. The plot shows the expression changes
(log2foldchanges) for each of the miRNAs at each time point post IPNV-challenge relative to controls. Several of the miRNA genes in the same miRNA family showed
similar dynamics and to simplify the plot only the major expressed mature member of each family is presented in the plot. The complete results are given in Table S2.
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significantly different to controls. There were sixteen miRNAs
from nine families in this cluster including the ssa-miR-29, 462,
and 731 families.
The second cluster included 11 miRNAs with expression
changing in different direction in RR and SS groups compared
to controls. As these changes were small when compared to
healthy controls, most of these were not significantly different
in the time point analysis at 20 dpc (Figure 2). There were five
miRNAs in this cluster with pronounced decreased expression
in RR and non-significant increased expression in SS, compared
to the controls (ssa-miR-novel-5-5p, ssa-miR-21a-1-3p, ssa-miR-
29d-5p, ssa-miR-146a-1-2-3p, and ssa-miR-2184-3p). These five
miRNAs grouped together in a sub-cluster within cluster 2
(shown as 2a, Figure 5). The remaining six miRNAs in cluster 2
(shown as sub-cluster 2b, Figure 5) were slightly downregulated
in the RR group and slightly upregulated in the SS group.
The HVL-DE miRNAs included in cluster 3 were those
characterized by large decreases in the SS group, while they
changed toward baseline expression that was not significantly
different to controls in the RR group. There were eleven miRNAs
from six familes in this cluster including the ssa-miR-192, miR-
459, and miR-8159 families.
In summary, the analysis of QTL-groups at 20 dpc revealed
38 miRNAs differentially expressed between the RR and the
SS groups. Compared to RR (and controls) there were 16
miRNAs with large increases in the SS group (cluster 1), while
there were 11 miRNAs with large decreases (cluster 3). The
remaining eleven miRNAs showed changes in different direction
in RR and SS groups when compared to the baseline level of
the controls. These miRNAs that were associated with QTL
genotype are the ones that could contribute to difference in
resistance/susceptibility to IPN.
Differentially Expressed miRNAs May
Regulate Immune Response Pathways
In silico Predictions of Target Genes
A means to better understand the functional significance of a
particular set of miRNAs showing differential expression is to
predict their target gene(s). Using in silico target gene analysis
we predicted the target genes of all the differentially expressed
miRNAs identified. A total of 2,434 different target transcripts
were predicted. A complete list of all predicted targets along with
the targeting DE miRNA and/or HVL-DE miRNA is given in
Table S4.
The GO annotations retrieved from the Uniprot database
(43) were used to limit our putative target gene set to include
only those transcripts with functional annotation associated with
immune system processes. There were 180 such putative target
genes. They were either Atlantic salmon virus responsive genes
(VRG) (45), or genes associated with immune responses [e.g.,
interferon regulatory factors (IRFs), C-C motif chemokines),
inflammation and/or apoptotic processes (e.g., tumor necrosis
factors (TNFs)]. All these genes are hereafter referred to as
“immune genes” to simplify the text flow. Table S5 shows these
immune genes along with the targetingDEmiRNAs and/orHVL-
DE miRNAs (differently expressed between RR and SS) shown
in separate rows. Hundred and seventy of these genes were
targeted by DE miRNAs while 148 genes were targeted by the 38
HVL-DE miRNAs.
A single miRNA may target several transcripts, and there
was a wide distribution in number of targets for the individual
miRNAs. Four of the miRNAs, ssa-miR-30d-2-3p, ssa-miR-
21a-2-3p, ssa-miR-30c-d-1-3p, and ssa-miR-183-5p, showed the
largest number of target matches (19, 17, 16, and 16 genes,
respectively). Seventeen other miRNAs (ssa-miR-10b-5p, ssa-
miR-10d-5p, ssa-miR-29a-3p, ssa-miR-29a-5p, ssa-miR-29b-3p,
ssa-miR-29c-3p, ssa-miR-125b-3-3p, ssa-miR-129-5p, ssa-miR-
143-3p, ssa-miR-146d-1-3p, ssa-miR-187-5p, ssa-miR-462a-3p,
ssa-miR-727b-3p, ssa-miR-731-5p, ssa-miR-8162-5p, ssa-miR-
novel-2-3p, and ssa-miR-novel-5-3p) also targeted from ten to
fifteen of the immune genes. The remaining DE miRNAs could
target from one up to nine of the immune genes. In the HVL-DE
miRNA group the ssa-miR-8159-5p and ssa-miR-21b-3p targeted
the largest number of genes (19 and 18 genes, respectively). Other
miRNAs with a larger number of targets in the HVL-DE miRNA
group were ssa-miR-731-5p (targeting 15 immune genes), and
ten members of the miR-29 family targeting from 6 to 14 genes.
Immune Response Pathways Associated With the
Targeted Immune Genes
Together the DE miRNAs and the smaller group of 38 HVL-
DE miRNAs were predicted to target several key genes involved
in the induction of Type I interferons (IFN-I), as well as
pro-inflammatory cytokines, which play major roles in the
defense response against viral infection in vertebrates (46, 47).
Enrichment analysis with the 180 putative target genes as input
were used to rank the gene pathways associated with all DE
miRNAs while an additional enrichment analysis was carried
out with the 148 predicted targets of the HVL-DE miRNAs
(differently expressed between RR and SS groups). The results
from these analysis’ are given in Table S6. Seven KEGG pathways
were those most enriched in target genes, each with combined
scores above 120 and p-adjusted values (Q score) <1.0−5
(Table S6). The enrichment analysis with target genes predicted
from the HVL-DE miRNAs also showed significant hits to
the same seven pathways. The seven pathways were: the toll-
like receptor signaling, the nucleotide-binding oligomerization
domain (NOD)-like receptor signaling, the cytokine-cytokine
receptor interaction, the apoptosis and the necroptosis pathways,
the retinoic acid-inducible gene I (RIG-I)-like receptor signaling
and the C-type lectin receptor (CLR) signaling. These pathways
and the predicted target genes are given in Figures S1–S3.
Table 1 shows the number of target genes predicted by all DE
miRNAs or only by the HVL-DE miRNAs for each of the gene
pathways. Table 2 shows the predicted genes in each pathway
while their full names and GenBank accession numbers are given
in Table S5. As shown in Table 2, several of the genes participate
in more than one of these pathways. We also note that different
paralogues e.g., the three Tumor necrosis factor alpha paralogues
are targeted by different DE miRNAs (see Table S5).
The cytokine-cytokine receptor interaction pathway had 24
genes that could be targeted by the DE miRNAs while 18
of these genes were predicted as targets for the miRNAs
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FIGURE 5 | Heat map and hierarchical clustering of the 38 HVL-DE miRNAs. Each row represents a miRNA, and the columns represents the expression changes
(log2foldchanges) in RR and SS groups at 20 dpc compared to controls. The dendrogram on the left shows the three major clusters of the HVL-DE miRNAs. The
direction of the miRNA expression changes (log2foldchanges) are illustrated on the color key. Black color represents the expression in controls (baseline expression),
red color indicates increased expression and green color indicates decreased expression. The color bars on the right indicate the three major clusters in which the
HVL-DE miRNAs with similar expression profiles were grouped.
Frontiers in Immunology | www.frontiersin.org 9 September 2020 | Volume 11 | Article 2113
Woldemariam et al. miRNAs Responding to IPNV Infection
differently expressed between RR and SS (HVL-DE miRNAs)
(see also Tables 1, 2, and Table S5). Among these target genes
were different chemokine receptors and their ligands that
are important regulators of the immune response (48). The
chemokine C-X-C motif chemokine 10 (CXL10, also known as
IP-10) has been shown to be induced by IFN gamma, poly I:C
and viral infections in Atlantic salmon (49–51). This chemokine
participating in three pathways (Table 1) was predicted as
target for ssa-miR-21b-3p, one of the 38 HVL-DE miRNAs,
and the Atlantic salmon specific miRNA, ssa-miR-novel-13-5p
(Table S5). Moreover, 20 genes that participate in the Toll-like
receptor signaling and 21 genes that participate in the NOD-
like receptor signaling pathways were putative targets for the DE
miRNAs while this was 15 and 18 genes, respectively from the
HVL-DE miRNAs (Tables 1, 2, and Table S5). Among the target
genes in the NOD-like receptor signaling pathway was myeloid
TABLE 1 | Gene pathways and number of targets predicted by all DE miRNAs vs.
HVL-DE miRNAs.
KEGG pathway No of predicted
target by all DE
miRNAs
No of predicted
targets by HVL-DE
miRNAs
sasa04620 Toll-like receptor
signaling
20 15
sasa04621 NOD-like receptor
signaling
21 18
sasa04060 Cytokine-cytokine
receptor Inter.
24 18
sasa04210 Apoptosis 15 9
sasa04622 RIG-I-like receptor
signaling
12 11
sasa04625 C-type lectin
receptor signaling
13 10
sasa04217 Necroptosis 13 11
differentiation primary response protein 88 (MYD88) that was
targeted by two HVL-DEmiRNAs (ssa-miR-29a-5p and ssa-miR-
29e-5p). The Atlantic SalmonMYD88 has been shown to interact
with Interferon Regulatory Factor 3 (IRF3) and 7 (IRF7), to
modulate IRF-dependent antiviral IFN response (52) (see below).
The RIG-I-like receptor signaling pathway had twelve genes
that could be targeted by the DE miRNAs and except one
of the TNF-A paralogs they were also predicted as targets
for the HVL-DE miRNAs (Tables 1, 2, and Table S5). The
suppressor of IKK-epsilon (SIKE), a negative regulator of the
RIG-I-pathway (53, 54), was predicted as a target for 15
miRNAs from 11 miRNA families (ssa-let-7a-1-3-3p, ssa-miR-
10b-5p, ssa-miR-10d-5p, ssa-miR-21a-2-3p, ssa-miR-21b-3p, ssa-
miR-26a-3-3p, ssa-miR-29e-5p, ssa-miR-143-3p, ssa-miR-146a-
1-2-3p, ssa-miR-146a-3-3p, ssa-miR-146b-3p, ssa-miR-183-5p,
ssa-miR-8159-5p, ssa-miR-novel-2-3p, and ssa-miR-novel-5-3p).
Another interesting target was the IRF3 that interacts with
MYD88. IRF3 is the main regulator of salmon IFN production
(47, 55). This key gene, participating in three pathways (Table 1),
was predicted as target for fourteen miRNAs from seven families
(ssa-miR-10 family, ssa-miR-18b-3p, ssa-miR-21 family, ssa-miR-
29 family, ssa-miR-30 family, ssa-miR-8159-5p and ssa-miR-
novel-5-3p). The same members of the ssa-miR-30 family (ssa-
miR-30c-d-1-3p and ssa-miR-30d-2-3p) could also target IRF7,
another MYD88 interacting IRF in this pathway. In addition,
three other miRNAs (ssa-miR-192a-5p, ssa-miR-459-3p and ssa-
miR-731-5p) also targeted IRF7.
Apoptosis and necroptosis (programmed necrotic cell death)
are important host response mechanism to counteract invading
pathogens, including viruses (56–58). Twenty-three different
genes that participate in apoptosis and/or necroptosis pathways
could be targeted by the DE miRNAs while 16 of these
were also targets of the HVL-DE miRNAs (Tables 1, 2 and
Table S5). Among the target genes involved in both pathways
were two death receptors of the tumor necrosis factor receptor
(TNFR) superfamily, Tumor necrosis factor receptor superfamily
TABLE 2 | Predicted target genes in the top seven enriched gene pathways.
KEGG pathwaya Genes namesb
sasa04620: Toll-like receptor
signaling
CATK; CXL10; IKKA; IRAK1; IRF3; IRF5; IRF7; M3K8; MAPK; MK03; MK13; MP2K2; MP2K4; MYD88; STAT1; TBK1;
TL/LRR; TNF-A; TNF-ALPHA-1; TNF-ALPHA-2
sasa04621: NOD-like receptor
signaling pathway
BRCC3; CATB; DNM1L; HS90A; HSP90AB1; IKKA; IRF3; IRF7; IRF9; MAPK; MK03; MK13; MYD88; RIPK4; STAT1;
STAT2; TBK1; TNF-A; TNF-ALPHA-1; TNF-ALPHA-2; TXNIP
sasa04060: Cytokine-cytokine
receptor interaction
CCL19; CCR6; CCR9; CD4; CD40L; CXCR3; CXCR4; CXL10; CXL14; I10R2; I12R2; I13R2; IL-1RL; IL2RB; IL31R; IL4RA;
TNF-A; TNF-ALPHA-1; TNF-ALPHA-2; TNF13; TNR14; TNR1A; TNR6; TR11B
sasa04210: Apoptosis CASP3; CATB; CATF; CATK; CATL1; CATS; IKKA; MCL-1; MK03; MP2K2; TNF-A; TNF-ALPHA-1; TNF-ALPHA-2; TNR1A;
TNR6
sasa04622: RIG-I-like receptor
signaling pathway
CXL10; DHX58; IKKA; IRF3; IRF7; MAPK; MK13; SIKE; TBK1; TNF-A; TNF-ALPHA-1; TNF-ALPHA-2
sasa04625: C-type lectin
receptor signaling pathway
BCL10; C209A; IKKA; IRF9; MAPK; MK03; MK13; NFKB2; STAT1; STAT2; TNF-A; TNF-ALPHA-1; TNF-ALPHA-2
sasa04217: Necroptosis DNM1L; HS90A; HSP90AB1; IRF9; RIPK4; STAT1; STAT2; STAT4; TNF-A; TNF-ALPHA-1; TNF-ALPHA-2; TNR1A; TNR6
aThe identification number and the name of the KEGG pathways to which the genes have been mapped (44).
bTarget genes names are from the Uniprot database (43), all in bold font are targets of HVL-DE miRNAs. The GenBank accession numbers are given in Table S5 in the
Supplementary Material along with full gene names.
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member 6 (TNR6) and Tumor necrosis factor receptor
superfamily member 1A (TNR1A) (56, 59), that were targeted by
seven (ssa-miR-10d-5p, ssa-miR-100a-2-3p, ssa-miR-187-5p, ssa-
miR-192a-5p, ssa-miR-726-3p, ssa-miR-727b-3p, and ssa-miR-
novel-13-5p) and five miRNAs (ssa-miR-18b-3p, ssa-miR-30c-
d-1-3p, ssa-miR-30d-2-3p, ssa-miR-183-5p, and ssa-miR-novel-
5-5p), respectively. The large number of targets predicted from
these two pathways suggest that the DE miRNAs, including
some HVL-DE miRNAs, are involved in regulation of key genes
that control programmed cell death (Apoptosis and Necroptosis
pathways, Figure S3).
Immune Genes Targeted by HVL-DE miRNAs With
Changed Expression at 20 dpc
The relationship between a differentially expressed miRNA
and its predicted target may be explored by additional
analysis of target gene expression. The gene expression in the
materials investigated in this study was examined in parallel by
microarray analysis (unpublished work by Dr. Diego Robledo
and colleagues). Twenty-five of the 180 immune genes predicted
as targets of the HVL_DE miRNAs were revealed as differentially
expressed in the SS group vs. the RR group at 20 dpc by
microarray analysis. These genes and the HVL-DE miRNAs
(different expression between RR and SS group at 20 dpc) that
were predicted to target the genes are shown in Table 3. Results
frommicroarray analysis revealed that all 25 genes showed higher
expression in the SS group vs. the RR group. In most cases the
HVL-DEmiRNAs showed similar change as the target genes (i.e.,
higher in the SS group vs. the RR group at 20 dpc). Although it
is expected that a miRNA regulating a target gene would show
opposite change in expression to its target, the changes in similar
direction could be explained by models where miRNAs fine-
tune target gene expression [see discussion and Andreassen and
Høyheim (13)].
Eleven of the 25 genes were targeted by only one miRNA.
It is, however, shown that a target gene may be regulated by
several miRNAs (60, 61). If one gene is targeted by several
miRNAs that change their expression in a similar manner,
this would add evidence that it is a true target gene. Five
such target genes were revealed. These were the C-C motif
chemokine 19 (CCL19), the Thioredoxin-interacting protein
(TXNIP), the Interleukin-10 receptor beta chain precursor
(I10R2), the Receptor-transporting protein 3 (RTP3) and the
VHSV-induced protein-like (LOC100194553) (Table 3). Other
targets also showed matches to several miRNAs, but often with
one miRNA changing expression in opposite direction vs. the
others. This could reflect a falsely predicted target site or that the
target gene regulation is more complex and may be fine-tuned by
miRNAs changing in different directions.
DISCUSSION
IPNV is an important viral pathogen that has had a major
impact on salmonid aquaculture. Analysis of the IPNV challenge
materials investigated here allowed us to compare viral load
and miRNA expression in family-matched fry with alternate
genotypes [IPN-QTL susceptible (SS) or IPNV-QTL resistant
(RR)]. Significant viral loads were detected in equal amounts in
both IPN-QTL genotypes (RR and SS) at 1 dpc. The absence
of an early difference (1 dpc) in viral loads between any of the
individuals is in agreement with other studies (21, 27).
The susceptible genotypes showed much higher average viral
load than resistant genotypes at 7 and 20 dpc. This is also in
agreement with the viral load measurements in Robledo et al.
(21). Some controls showed positive, but very low amounts
of IPNV. They were still included as we assumed this was
contamination at challenge initiation, and the higher number of
controls would lead to a better estimate of variation. The controls
were sampled prior to challenge initiation and challenged
samples from 1, 7, and 20 dpc were compared to these. The 38
HVL-DE miRNAs differentially expressed in the SS group were,
however, not significantly different expressed when comparing
the low-viral RR-group with the controls. This indicates that
the miRNA expression changes reflect differences in response to
IPNV rather than being a time related bias.
Previous studies have indicated that host-cell miRNAs play
a key role in fine-tuning Atlantic salmon immune response
to viral infection (12, 13). In the present study, we identified
miRNAs that showed expression changes in response to IPNV
at different time points compared to controls, but not necessary
different between RR and SS groups (DE miRNAs). The other
group of miRNAs that could affect the resistance/susceptibility
where those that showed differences between the SS group with
high viral loads and the RR groups with low viral load (HVL-
DE miRNAs). These were only detected at 20 dpc. Finally, we
explored the role of the DE miRNAs in the immune response
by in silico prediction of their immune-relevant target genes. The
analysis ofmiRNA expression in the time point analysis identified
72 Atlantic salmon miRNAs that showed dynamic expression
changes indicating a temporal regulation of themiRNA responses
following IPNV challenge (DE miRNAs, Figure 2). Similar
dynamic changes involving many of the same miRNAs were
observed in a challenge study with Salmonid Alpha virus (SAV)
(12). The 72 DE miRNAs could, in general, be divided into
two groups; those with downregulated expression in challenged
groups between 7 and 20 dpc (Figures 3, 4), and those that
showed upregulated expression at 20 dpc (Figures 3, 4). The fact
that many of the same miRNAs responded to IPNV challenge
in a similar manner as to SAV challenge (12) indicates that they
are part of the general immune response to viral infection rather
than a particular response to IPNV (or SAV). Moreover, some
conserved miRNAs (e.g. miRNAs from families 21, 146, 181,
462, and 731) have shown similar responses to viral challenge
in many different teleosts (13, 62). This further indicates that
they contribute to the regulation of common immune and
anti-viral response genes. However, the particular response and
magnitude of change in different teleost fish could depend, and
be manipulated by, the pathogen (13, 62, 63).
There was a clear difference in response to infection between
the high viral load SS group and the low viral load RR group.
However, the differences in miRNA expression between the SS
group and the RR group (HVL-DE miRNAs) were only detected
at the latest time point (i.e., 20 dpc). Thus, this appears as a late
response to themore severe viral infection in theHVL individuals
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TABLE 3 | Immune genes differentially expressed between the RR and SS groups that were predicted as targets of the HVL-DE miRNAs at 20 dpc.
Target genea Immune functionb HVL-DE miRNAs, SS, vs. RRc
Toll-like leucine-rich repeat protein
(TL/LRR)
Activator, inflammatory responses to pathogens, Innate immunity ↑ miR-731-5p
Signal transducer and activator of
transcription 3 (STAT3)
Activator, acute-phase response, host-virus interaction, regulation of type I interferon signaling
pathway, viral process
↓ let-7d-c-1-3p
↑ ssa-miR-18b-3p
Signal transducer and activator of
transcription 2 (STAT2)
Activator, antiviral defense, host-virus interaction, cytokine-mediated signaling pathway,
regulation of type I interferon signaling pathway, viral process
↓ let-7d-c-1-3p,
↑ miR-18b-3p
Tumor necrosis factor alpha-1
(TNF-alpha-1)
Activator, inflammatory response, I-kappaB kinase/NF-kappaB signaling, extrinsic apoptotic
signaling pathway via death domain receptors, humoral immune response
↑ miR-novel-5-3p
E3 ubiquitin-protein ligase
TRIM39-like (LOC106608979)
Activator, positive regulation of apoptotic signaling pathway ↑ miR-7a-2-6-3p
Interferon regulatory factor 3 (IRF3) Activator, transcription factor activating innate immunity pathway, antiviral defense against DNA
and RNA viruses, host-virus interaction
↓ miR-8159-5p
↑ miR-18b-3p
↑ miR-21b-3p ↓
↑ miR-29a-3p
↑ miR-29b-3-5p
↑ miR-29de-3p
↑ miR-29c-3p
↑ miR-novel-5-3p
Interferon regulatory factor 7 (IRF7) Activator, transcription factor activator that promote inflammation, antiviral defense against
DNA and RNA viruses, critical for the late than for the early phase of the IFN gene induction.
↓ miR-192a-5p
↓ miR-459-3p
↑ miR-731-5p
C-C motif chemokine 19 (CCL19) Cytokine, virus responsive gene, immune response, Inflammatory response, innate immunity
pathway
↑ miR-26a-3-3p
↑ miR-731-3p
Thioredoxin-interacting protein
(TXNIP)
Transcriptional repressor, required for the maturation of natural killer cells, positive regulation of
apoptotic process
↓ let-7a-1-3-3p
↓ miR-8159-3p
Angiopoietin-related protein 4
precursor (ANGL4)
Inhibitor, negative regulation of apoptotic process ↓ miR-192a-1-3p
↓ miR-192b-5p
↑ miR-29a-5p
↑ miR-29e-5p
↑ miR-7a-2-6-3p
C-X-C motif chemokine 10 precursor
(CXL10)
Pro-inflammatory cytokine, involved in chemokine-mediated signaling pathway, immune
response
↑ miR-21b-3p ↓
C-X-C chemokine receptor type 3
(CXCR3)
Receptor for C-X-R chemokines, regulates biological processes such as immune response,
inflammatory, response, and apoptotic process
↓ miR-8159-5p
↑ miR-731-5p (2x)
↑ miR-7a-2-6-3p
Interleukin-4 receptor alpha chain
precursor (IL4RA)
Receptor, cytokine-mediated signaling pathway, immune response, production of molecular
mediators involved in inflammatory response
↑ miR-novel-5-3p
Interleukin-10 receptor beta chain
precursor (I10R2)
Receptor, virus responsive gene, cytokine-mediated signaling pathway, antiviral defense
response, immune response, inflammatory response
↑ miR-18b-3p
↑ miR-221-5p
↑ miR-29b-2-5p
↑ miR-29c-5p (2x)
Probable ATP-dependent RNA
helicase DHX58 (DHX58)
Virus responsive gene, host-virus interactions, innate immune response to RNA viruses and
some DNA viruses such as poxviruses, negative regulator of DDX58/RIG-I and IFIH1/MDA5
mediated antiviral signaling
↑ miR-731-5p
Interferon-induced protein with
tetratricopeptide repeats 5-like (IFIT5)
Virus responsive gene, defense response to virus, innate immune response, negative regulation
of viral genome replication, positive regulation of I-kappaB kinase/NF-kappaB signaling
miR-2184-3p ↓
XIAP-associated factor 1 (XAF1) Virus responsive gene, pro-apoptotic gene, regulation of apoptotic process ↓ miR-122-5p
↑ miR-146d-1-3p
↑ miR-29b-3-5p
Macrosialin precursor (CD68) Virus responsive gene ↓ let-7b-3p
↑ miR-731-5p
↑ miR-462a-3p (5x)
Interferon-induced transmembrane
protein 5 (IFM5)
Virus responsive gene ↑ miR-21b-3p ↓
Receptor-transporting protein 3
(RTP3)
Virus responsive gene ↑ miR-29a-3p,
↑ miR-29de-3p,
↑ miR-29c-3p
IFN-inducible protein Gig2-like-1 Virus responsive gene ↑ miR-462a-3p
(Continued)
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TABLE 3 | Continued
Target genea Immune functionb HVL-DE miRNAs, SS, vs. RRc
Interferon-induced protein 44 (IFI44) Virus responsive gene, antiviral defense, immune response ↑ miR-21b-3p ↓
Barrier-to-autointegration factor (BAF) Virus responsive gene, host-virus interaction, known be exploited by retroviruses to facilitate
integration of retroviruses in host genomes
↑ miR-21b-3p ↓
VHSV-induced protein-like
(LOC100194553)
Virus responsive gene, immune response ↑ miR-221-5p,
↑ miR-29b-1-5p ↓
↑ miR-29c-5p
miR-29d-5p ↓
VHSV-inducible protein (VHSV) Virus responsive gene, upregulated in VHSV ↓ let-7d-c-1-3p,
miR-29d-5p ↓
aTarget genes names as annotated in the Uniprot database (43).
bThe description of immune functions are based on GO terms in the Uniprot database and Krasnov et al. (45).
cHVL-DE miRNAs with target site matches in the 3’UTRs of the target genes. For space saving reasons the ‘ssa’prefix was removed. Upward arrows (↑) illustrate higher expression,
and downward arrows (↓) indicate lower expression in the SS group vs. the RR group at 20 dpc. In cases where the HVL-DE miRNAs showed large changes in different directions,
the arrow prior to miRNA name denotes change in SS, and arrow behind miRNA denotes change in RR (Figure 5). If a miRNA has multiple matches to a target this is indicated in the
following brackets.
(SS group showing much higher viral loads from 7 dpc). The 38
HVL-DE miRNAs could be clustered into three groups: miRNAs
responding to viral infection with more pronounced changes
(either increases or decreases) in the SS group vs. controls
(Cluster 1 and 3, Figure 5), or miRNAs with expression changes
in different directions in the HVL-SS and the LVL-RR groups
compared to controls (Cluster 2, Figure 5). This last group is
interesting, as these miRNAs, including the miR-21, miR-146 and
miR-2184 family members, would contribute opposite regulation
of their target genes compared to the expression level of the
non-infected samples in the later phase of the inflammatory
response. Since the HVL-DE miRNAs were the ones differently
expressed between the RR and SS group it is possible that they
contribute to differences in resistance/susceptibility, but as in any
study revealing association, the association alone is not enough to
verify causation.
Analysis of potential target mRNAs is essential for revealing
the biological processes and to identify the gene pathways that
are regulated by miRNAs. The target genes may be predicted by
in silico analysis where the putative target sites in the 3’UTRs
are identified. Such predictions commonly result in many false
positives when the complete transcriptome is used as input
(13). Here, we applied a stepwise approach to single out the
most likely targets (Figure 6). First the transcriptome was used
as input, then the target genes with immune related functions
(immune genes) were singled out, and finally, those immune
genes with significant expression differences between the SS
group and the RR group at 20 dpc were identified. Assuming
that the miRNAs do contribute to fine-tuning the immune
response, the 25 immune genes changing their expression at
the same stage in the same materials would be the most likely
targets (Table 3). Studies have shown that several genes involved
in type I IFN and antiviral immunity pathways participate in
host response to IPNV (21, 26–29, 47), and several of the
DE and HVL-DE miRNAs were predicted to target genes that
regulate antiviral immunity pathways, such as those leading
to Type I IFN response (e.g., IRFs and STATs) (Table 2).
Interestingly, many of the genes participating in these pathways
were also among the 25 genes differentially expressed between
the SS and RR groups (Table 3). The functional annotation and
enrichment analysis illustrated that the miRNAs responding to
IPNV could contribute to the regulation of most of the important
signaling pathways activated upon viral infection by targeting
multiple genes as illustrated in the seven KEGG pathways
(Figures S1–S3).
Interpretation of the function of each individual miRNA
is complicated by the possibility that some targets are falsely
predicted. It is also difficult to interpret because their expression
changes from one time point to another post challenge, which
leads to different effects on their target gene. In the proposed
model for miRNA function in teleost fish immune homeostasis
(13) we suggested that the dynamic expression of miRNAs
changes according to what would benefit the host anti-viral
defense during the infection. In this model, the miRNA and its
target transcript do not necessarily show inverse proportional
expression. In the late stage of viral infection, both a miRNA
contributing to fine-tuning the expression of the inflammatory
activators as well as the activators themselves could show
increased expression. This could help fine-tune the elevated
expression of the activator at a level where the inflammatory
processes protect against virus but are not increased to levels
where it is harmful to the host. A model with such multiple
functions for several miRNAs is supported by findings in studies
of innate immunity response and autoimmune diseases in
higher vertebrates (64–66). Finally, the interpretation of miRNA
function is complicated because the observed miRNA responses
are from challenge studies. The pathogens cause disease as
they have the ability to escape the host defense and sometimes
manipulate the host response to benefit their own propagation
(63, 67). Thus, what one observes may not be the miRNA
expression change that serves the host, but in some cases,
rather a pathogen-manipulated expression change that benefits
pathogen propagation.
Nevertheless, several of the DE and HVL-DE miRNAs
responded in accordance with the proposed dynamic model (13).
They showed decreased expression at 7 dpc and their predicted
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FIGURE 6 | Number of miRNA targets identified by our stepwise approach (n = 2,434). The targets with GO terms associated with immune functions are shown in
light blue (n = 180), while the immune genes showing different expression in comparison of the RR groups and SS groups (n = 148) are shown in blue, and finally the
immune genes differently expressed at 20 dpc (microarray analysis) and predicted as target for HVL-DE miRNAs are shown in dark blue (n = 25).
target genes were part of signaling pathways that induce a
host-protective response. Therefore, a decreased expression of
miRNAs that target these genes would contribute to promote
the immune response. Likewise, others that were upregulated
at 20 dpc were predicted to target inflammatory activators, and
an increased expression at 20 dpc could in these cases prevent
further escalation of inflammatory processes.
Regulation of many predicted targets is not straightforward to
interpret. For example, IRF3, a key gene in activation of immune
responses showed increased expression in the SS (HVL) group
vs. RR (LVL) group at 20 dpc (Robledo et al., unpublished)
demonstrating that this gene is involved in response to IPNV
infection. Fourteen miRNAs were predicted to target IRF3
(Table 4). The decreased expression of the six miRNAs [miR-
10, miR-21, and miR-30 family members, two from each family
(Table 4)] at 7 dpc could be a response to viral infection,
and their decreases would contribute to activate the host
antiviral responses by increasing the expression of IRF3 at
this stage of infection. At 20 dpc eight miRNAs responded
to the inflammatory level in the SS group by increasing their
miRNA expression, while these changes did not occur in the
RR group (Table 4). This would inhibit further increase of IRF3
expression in the SS group. These changes could help to contain
and balance the level of inflammatory response, which may be
harmful to the host over time. The decrease of ssa-miR-8159-
5p only in the SS groups at 20 dpc does however, not fit the
model. One explanation could be that IRF3 is a falsely predicted
target for this miRNA. Nevertheless, IRF3 and the predicted
miRNA interactions do illustrate that theremight be complex and
dynamic host-cell miRNA fine-tuning mechanisms acting during
viral infections.
Another interesting result revealed was that paralogs could be
regulated by different miRNAs. The salmon genome consists of
a large number of closely related paralogs due to a salmonid-
specific whole genome duplication that occurred ∼80 million
years ago (68, 69). Tumor necrosis factor (TNF) alpha is a pro-
inflammatory cytokine that plays a key role in regulation of
inflammation and immunity.Multiple paralogs of tumor necrosis
factor alpha have been identified in teleost species, including
Atlantic salmon (70, 71). Our predictions showed that TNF-
ALPHA-2 was targeted by ssa-miR-222b-5p, while TNF-ALPHA-
1- was targeted by ssa-miR-222b-5p and the species-specific
miRNA ssa-miR-novel-5-3p. In contrast, TNFA was targeted by
seven other miRNAs (ssa-miR-21a-2-3p, ssa-miR-21b-3p, ssa-
miR-146d-1-3p, ssa-miR-183-5p, ssa-miR-192a-5p, ssa-miR-459-
3p, and ssa-miR-8159-5p) (Table S5). This demonstrates that
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TABLE 4 | Expression changes in the 14 miRNAs that were predicted to target
IRF3.
miRNAsa 1 dpcb 7 dpcb 20 dpc-SSc 20 dpc-RRc
ssa-miR-10d-5p 0.7 −1.2 −1.4 −1.0
ssa-miR-10b-5p 0.7 −1.2 −1.4 −1.0
ssa-miR-30c-d-1-3p 0.7 −1.1 −1.2 −1.0
ssa-miR-30d-2-3p 0.7 −1.1 −1.2 −1.0
ssa-miR-21a-2-3p 0.4 −1.9 −1.4 −1.8
ssa-miR-21b-3p 0.4 −0.7 1.1 −0.6
ssa-miR-18b-3p 0.1 −0.1 1.0 −0.4
ssa-miR-novel-5-3p 0.5 −0.2 2.2 −0.5
ssa-miR-29b-3-5p 0.9 −0.2 0.6 −0.4
ssa-miR-29b-3p −0.1 0.6 1.5 0.6
ssa-miR-29a-3p −0.1 0.2 1.7 0.5
ssa-miR-29c-3p 0.2 0.4 2.3 0.6
ssa-miR-29de-3p −0.4 0.5 2.5 0.7
ssa-miR-8159-5p 0.0 0.3 −1.9 0.2
aMature Atlantic salmon miRNA names as annotated in Woldemariam et al. (33).
b log2 fold change from DESeq2 analysis of IPNV challenged samples vs. controls at 1
and 7 dpc, respectively.
c log2 fold change from DESeq2 analysis of IPNV challenged SS groups vs. controls and
RR groups vs. controls at 20 dpc, respectively.
when genes undergo duplication, the extra gene copies are free
to assume new functions including different regulatory responses
(72). These results also demonstrate the importance of full-
length transcript sequence information on paralogous genes to
understand the miRNA mediated gene regulatory mechanisms.
In summary, although a number of immune genes were
predicted as targets, often for several of the responding
miRNAs, the target-miRNA interactions seem too complex to
be fully understood from the expression analysis and the target
predictions alone. Despite these limitations, the presented results
showed that the DE miRNAs could together target genes that
are part of several different gene pathways. Predicted targets
were revealed in pathways that induce Type I interferons (IFN-
I) (e.g., Toll-like receptor signaling, NOD-like receptor signaling
and RIG-I receptor signaling) as well as apoptosis regulators.
Most of these immune genes were also targeted by HVL-
DE miRNAs which opens the possibility that some miRNAs
contribute to differences in resistance/susceptibility at the later
stages of infection. Our further studies will aim to investigate
the predicted miRNA-target gene interactions from this study
by functional approaches to uncover the role of the miRNAs in
IPNV pathogenesis mechanisms.
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